In summary, participants with NAFLD at baseline showed greater changes in liver fat content and improvements in liver function and insulin sensitivity with moderate diet-induced weight loss than individuals without NAFLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.